Medical cannabis endorsement requirements modified.
This bill modifies Minnesota's medical cannabis endorsement requirements, primarily affecting businesses that cultivate, process, or sell medical cannabis products. It updates rules for retail endorsements by requiring retailers to employ either a licensed pharmacist or a certified medical cannabis consultant to provide final authorization for patient product distribution. The legislation also clarifies that retail businesses must verify patient registry enrollment and confirm proper product selection through consultation with qualified medical professionals before dispensing cannabis. Additionally, the bill mandates that all medical cannabis products undergo safety, potency, and consistency testing at approved facilities before being distributed to patients. These changes aim to standardize oversight and ensure qualified professionals oversee the final approval of medical cannabis products for patients.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 16, 2026
Last action Mar 16, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Mar 16, 2026
Introduced
Introduction and first reading, referred to Commerce Finance and Policy
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Keith Allen
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HF 4412
Scope: MN
Hi! I can help you understand HF 4412. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline